Travere Therapeutics (TVTX) Treasury Shares (2013 - 2025)
Travere Therapeutics (TVTX) posted Treasury Shares of $233604.0 for Q4 2025, down 93.36% on a QoQ basis from $3.5 million in Q4 2024, and down 93.36% year-over-year from $3.5 million in Q4 2024.
Travere Therapeutics (TVTX) Treasury Shares (2013 - 2025) Analysis & Trends
Travere Therapeutics' Treasury Shares history runs 13 years deep, the most recent figure standing at $233604.0 for Q4 2025.
- Quarterly Treasury Shares rose 235.85% year-over-year to $3.2 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $3.2 million (up 235.85% YoY) and the FY2014 annual result came in at $3.2 million, up 235.85% from the prior year.
- Treasury Shares was $3.2 million for Q4 2014 at Travere Therapeutics, roughly flat from $3.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $3.2 million in Q4 2014 and bottomed at $957272.0 in Q4 2013.
- A 5-year average of $1.5 million and a median of $1.5 million in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 1904.62% — and 2025, when it slumped 93.36%.
- Travere Therapeutics' Treasury Shares stood at $957272.0 in 2013, then jumped by 235.85% to $3.2 million in 2014.
- Business Quant data shows TVTX's Treasury Shares at $3.2 million in Q4 2014, $3.2 million in Q3 2014, and $957272.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 233,604.00 |
| Dec 31, 2025 | 233,604.00 |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | 175,458.00 |
| Dec 31, 2023 | 175,458.00 |
| Dec 31, 2022 | 2.34 Mn |
| Dec 31, 2022 | 2.34 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 167,500.00 |
| Dec 31, 2020 | 167,500.00 |
| Dec 31, 2019 | 763,728.00 |
| Dec 31, 2019 | 763,728.00 |
| Dec 31, 2018 | 226,750.00 |
| Dec 31, 2018 | 226,750.00 |
| Dec 31, 2017 | 250,500.00 |
| Dec 31, 2017 | 250,500.00 |
| Dec 31, 2016 | 407,746.00 |
| Dec 31, 2016 | 407,746.00 |